CA17129 – Catalysing transcriptomics research in cardiovascular disease
CardioRNA COST Action CA17129 is a collaborative pan-European network of multidisciplinary researchers, clinicians, and industrial partners aiming to accelerate the understanding of transcriptomics in cardiovascular disease (CVD) and further the translation of experimental data into usable applications to improve personalized medicine in this field.
Seventh call for CardioRNA STSM fellowshipsNovember 8, 2021
The COST Action CardioRNA CA17129 (https://www.cost.eu/actions/CA17129) is launching the seventh call for Short-Term Scientific Mission (STSM) fellowships. STSMs are exchange visits aimed at supporting individual mobility, strengthening existing networks, fostering collaboration between COST Action Participants. STSMs should specifically contribute to the scientific objectives of the Action, whilst at the same time allowing those partaking in […]
New CardioRNA Position paper: Peripheral blood RNA biomarkers for cardiovascular diseaseNovember 4, 2021
Very happy to share the latest EU-CardioRNA position paper out now in Cardiovascular Research. Congratulations to Maarten Vanhaverbeke, Yvan Devaux and all co-authors. A practical how-to and bench-to-bedside guide study RNA biomarkers in CVD. Access the PDF here: Cvab327 Abstract: Despite significant advances in the diagnosis and treatment of cardiovascular diseases, recent 4 calls have […]
Open Access Week offer: APC waiver for the CardioRNA Special Issue in Non-coding RNA ResearchSeptember 18, 2021
As part of their Open Access week campaign, KeAi publishing and Non-coding RNA Research are going to waive the article publishing charge (APC) for the articles submitted to the CardioRNA Special Issue during this week. The Special issue on RNAs in diagnosis and treatment of cardiovascular diseases is open now for submissions, with Guest editors Drs Emma […]